RhumbLine Advisers’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-49,190
Closed -$1.69M 3060
2014
Q4
$1.69M Buy
49,190
+35
+0.1% +$1.14K ﹤0.01% 1472
2014
Q3
$1.47M Sell
49,155
-4,460
-8% -$94.5K ﹤0.01% 1523
2014
Q2
$1.08M Sell
53,615
-1,333
-2% -$30.6K ﹤0.01% 1771
2014
Q1
$1.49M Sell
54,948
-1,450
-3% -$38.5K ﹤0.01% 1545
2013
Q4
$1.17M Buy
56,398
+1,930
+4% +$36.4K ﹤0.01% 1700
2013
Q3
$993K Buy
54,468
+138
+0.3% +$2.49K ﹤0.01% 1789
2013
Q2
$904K Buy
+54,330
New +$868K ﹤0.01% 1830

Other funds holding AUXL

RhumbLine Advisers's AUXL Position: Q1 2015 in Review

RhumbLine Advisers sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 49,190 shares — an estimated $1.69M sold.

RhumbLine Advisers first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $1.69M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • RhumbLine Advisers reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 49,190 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $1.69M.
  • RhumbLine Advisers first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • RhumbLine Advisers's AUXILIUM PHARAMCEUTICALS INC position peaked at $1.69M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.